Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer - Centre Georges Francois Leclerc Access content directly
Journal Articles Clinical Genitourinary Cancer Year : 2021

Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer

Rémi Pelloux-Prayer
  • Function : Author
Philomène Schiele
Stéphane Oudard
  • Function : Author
Gwenaëlle Gravis
CV
François Kleinclauss
Gilles Crehange
  • Function : Author
Equipe IFTIM [ImViA - EA7535]
Christophe Hennequin
  • Function : Author
Alicia Morgans
  • Function : Author
Lionel Geoffrois
  • Function : Author
Samuel Limat
  • Function : Author
Antoine Thiery-Vuillemin
  • Function : Author
Virginie Nerich

Domains

Biological Physics [physics.bio-ph]
Fichier principal
Vignette du fichier
S1558767321000859.pdf (340.39 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Accord Elsevier CCSD  : Connect in order to contact the contributor

https://hal.science/hal-03612906

Submitted on : Monday, October 16, 2023-1:26:38 PM

Last modification on : Monday, January 8, 2024-11:16:04 AM

Long-term archiving on: Wednesday, January 17, 2024-8:06:03 PM

Download

Dates and versions

hal-03612906 , version 1 (16-10-2023)

Licence

Attribution - NonCommercial

Identifiers

Elsevier-hosted Accepted Manuscript

Cite

Rémi Pelloux-Prayer, Philomène Schiele, Stéphane Oudard, Gwenaëlle Gravis, François Kleinclauss, et al.. Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer. Clinical Genitourinary Cancer, 2021, 19 (5), pp.e326-e333. ⟨10.1016/j.clgc.2021.03.022⟩. ⟨hal-03612906⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BOURGOGNE FNCLCC CGFL IMVIA
29 View
11 Download

Altmetric

Share

Gmail Facebook X LinkedIn More